Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Chen

Showing results (421-430 of 437) with videos related to

Pageof 44
Sort By:
The New England Journal of Medicine|July 14, 2021
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19Michael Dougan, Ajay Nirula, Masoud Azizad, et al.
Nature|September 4, 2024
An aberrant immune-epithelial progenitor niche drives viral lung sequelaeHarish Narasimhan, In Su Cheon, Wei Qian, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2021
A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral LoadMichael Dougan, Masoud Azizad, Bharat Mocherla, et al.
The Lancet. Microbe|May 30, 2024
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort studyTomas O Jensen, Thomas A Murray, Greg A Grandits, et al.
The Journal of Infectious Diseases|November 10, 2023
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19Tomas O Jensen, Greg A Grandits, Mamta K Jain, et al.
Critical Care Explorations|June 22, 2026
Impact of Fostamatinib on Inflammatory Biomarkers in Hospitalized Patients With COVID-19Raquel S Da Cruz, Heather L Teague, Marcos J Ramos-Benitez, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|March 30, 2013
American Society of Echocardiography Cardiovascular Technology and Research Summit: a roadmap for 2020Patricia A Pellikka, Pamela S Douglas, James G Miller, et al.
Hemasphere|November 27, 2025
Inflammatory disorders in IDH-mutated myeloid neoplasms: Characteristics and response to IDH inhibitorsRomain Stammler, Peter Chen, Orianne Debeaupuis, et al.
The Journal of Physical Chemistry Letters|April 8, 2017
Performance Characterization of Dye-Sensitized Photovoltaics under Indoor LightingChia-Yuan Chen, Zih-Hong Jian, Shih-Han Huang, et al.
JAMA|April 11, 2023
Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical TrialsWesley H Self, Matthew S Shotwell, Kevin W Gibbs, et al.
Pageof 44

Showing results (421-430 of 437) with videos related to

Sort By:
Pageof 44
The New England Journal of Medicine|July 14, 2021
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19Michael Dougan, Ajay Nirula, Masoud Azizad, et al.
Nature|September 4, 2024
An aberrant immune-epithelial progenitor niche drives viral lung sequelaeHarish Narasimhan, In Su Cheon, Wei Qian, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2021
A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral LoadMichael Dougan, Masoud Azizad, Bharat Mocherla, et al.
The Lancet. Microbe|May 30, 2024
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort studyTomas O Jensen, Thomas A Murray, Greg A Grandits, et al.
The Journal of Infectious Diseases|November 10, 2023
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19Tomas O Jensen, Greg A Grandits, Mamta K Jain, et al.
Critical Care Explorations|June 22, 2026
Impact of Fostamatinib on Inflammatory Biomarkers in Hospitalized Patients With COVID-19Raquel S Da Cruz, Heather L Teague, Marcos J Ramos-Benitez, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|March 30, 2013
American Society of Echocardiography Cardiovascular Technology and Research Summit: a roadmap for 2020Patricia A Pellikka, Pamela S Douglas, James G Miller, et al.
Hemasphere|November 27, 2025
Inflammatory disorders in IDH-mutated myeloid neoplasms: Characteristics and response to IDH inhibitorsRomain Stammler, Peter Chen, Orianne Debeaupuis, et al.
The Journal of Physical Chemistry Letters|April 8, 2017
Performance Characterization of Dye-Sensitized Photovoltaics under Indoor LightingChia-Yuan Chen, Zih-Hong Jian, Shih-Han Huang, et al.
JAMA|April 11, 2023
Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical TrialsWesley H Self, Matthew S Shotwell, Kevin W Gibbs, et al.
Pageof 44